In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 1, 2013, Pages 126-130

  Cobrado, L ^a,b   Silva Dias, A ^a   Azevedo, M M ^a   Pina Vaz, C ^a,b   Rodrigues, A G ^a,b  

^a University of Porto   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Biofilm inhibition; CRBSIs; Nosocomial infections

Indexed keywords

CERIUM; CHITOSAN; HAMAMELITANNIN; POLYURETHAN; TANNIN DERIVATIVE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BIOFILM; CANDIDA ALBICANS; CATHETER; CONCENTRATION RESPONSE; DISINFECTION; FEMALE; FOREIGN BODY; FUNGAL METABOLISM; FUNGAL STRAIN; IN VIVO STUDY; MICROBIAL BIOMASS; MOUSE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-INFECTIVE AGENTS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; CATHETER-RELATED INFECTIONS; CERIUM; CHITOSAN; FEMALE; GALLIC ACID; HEXOSES; MICE; MICE, INBRED BALB C; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84871202688     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks376     Document Type: Article

References (13)

1. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598-601.
2. Oda T, Hamasaki J, Kanda N et al. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology 1997; 87: 1242-4.
3. Kalfon P, de Vaumas C, Samba D et al. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 2007; 35: 1032-9.
4. Gilbert RE, Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Curr Opin Infect Dis 2008; 21: 235-45.
5. Cobrado L, Azevedo MM, Silva-Dias A et al. Cerium, chitosan and hamamelitannin as novel biofilm inhibitors?. J Antimicrob Chemother 2012 67: 1159-62.
6. Rabea EI, Badawy ME, Stevens CV et al. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003; 4: 1457-65.
7. Kiran M, Adikesavan N, Cirioni O et al. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Mol Pharmacol 2008; 73: 1578-86.
8. Rupp ME, Ulphani JS, Fey PD et al. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun 1999; 67: 2627-32.
9. Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 2008; 72: 157-65.
10. Uppuluri P, Chaturvedi AK, Srinivasan A et al. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog 2010; 6: e1000828.
11. Garner JP, Heppell PS. Cerium nitrate in the management of burns. Burns 2005; 31: 539-47.
12. Martinez LR, Mihu MR, Tar M et al. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model. J Infect Dis 2010; 201: 1436-40.
13. Cobrado L, Espinar MJ, Costa-de-Oliveira S et al. Colonization of central venous catheters in intensive care patients: a 1-year survey in a Portuguese university hospital. Am J Infect Control 2010; 38: 83-4.